Skip to content

Chlamydia trachomatis MOMP Antigen BA1372VSR2

$1,024.00

Summary

  • Virion/Serion Immunologics Antigen for research use (RUO)
  • Chlamydia trachomatis MOMP Antigen, recombinant
  • Suitable for detection of IgA, IgG & IgM antibodies in ELISA
  • Lot specific concentration, specified in mg/mL
  • 1 mg
SKU: BA1372VSR2 Category: Tags: ,
Weight 1 lbs
Dimensions 9 × 5 × 2 in
target

Chlamydia trachomatis MOMP

species reactivity

Chlamydia pneumoniae

applications

ELISA

assay type

Indirect & quantitative

available size

1 mg

Chlamydia trachomatis MOMP Antigen BA1372VSR2

kit
Research area
Infectious Disease
Storage
Store at -65°C or lower. Avoid repeated freeze-thaw cycles. 10 years from date of manufacture (under recommended storage conditions).
Form
liquid
Associated products
Chlamydia trachomatis EB + RB Antigen (BA1372VSER)
Chlamydia trachomatis MOMP Antigen (BA1372VSR2)
Chlamydia trachomatis IgA Control Serum (BC1372A)
Chlamydia trachomatis IgG Control Serum (BC1372G)
Chlamydia trachomatis IgM Control Serum (BC1372M)
Chlamydia trachomatis IgA ELISA Kit (ESR1372A)
Chlamydia trachomatis IgG ELISA Kit (ESR1372G)
Chlamydia trachomatis IgM ELISA Kit (ESR1372M)
Chlamydia IgA ELISA Kit (ESR137A)
target relevance
Organism
Chlamydia pneumoniae
Protein names
Chlamydia pneumoniae
Structure and strains
Chlamydia pneumoniae is a species of Chlamydia, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia. It was known as the Taiwan acute respiratory agent (TWAR) from the names of the two original isolates Taiwan (TW-183) and an acute respiratory isolate designated AR-39. Briefly, it was known as Chlamydophila pneumoniae, and that name is used as an alternate in some sources. In some cases, to avoid confusion, both names are given.
Detection and diagnosis
Diagnosis of a Chlamydia pneumoniae infection is usually based on serological analysis by detection of specific serum antibodies. In the past, the microimmunofluorescence (MIF) test has been used as a reference method. However, it is increasingly replaced by species-specific ELISA tests, which allow for better standardization and automation. Seroprevalence rates rise rapidly in preschool age and reaches >50% after adolescence. Later on in life, the prevalence of C. pneumoniae increases even further due to frequently reoccurring infections and due to its propensity to lead to chronic disease. Beyond 65 years of age, seroprevalence may reach 70-100%. Seroprevalence rates for IgA are barely lower (approximately 60-70%) than for IgG

Data

Publications

Publications

pmid title authors citation
We haven't added any publications to our database yet.
Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.

Protocols

relevant to this product
BA1372VSR2 protocol

Documents

Product data sheet
BA1372VSR2